Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer

NCT00494338 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00494338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00494338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2004
Completion date
April 30, 2005
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer